A 42-year-old woman with generalized pustular psoriasis (Zumbusch type) is admitted with fever, systemic toxicity, and electrolyte imbalance. Topical therapy is ineffective. Which is the drug of choice for acute management?

Explanation

## Acute Management of Severe Pustular Psoriasis **Key Point:** Cyclosporine is the drug of choice for acute, life-threatening pustular psoriasis (Zumbusch type) because of its rapid onset of action (2–4 weeks) and potent anti-inflammatory effect, making it ideal for acute flares with systemic toxicity. ### Clinical Context: Zumbusch Pustular Psoriasis **High-Yield:** Zumbusch pustular psoriasis is a rare, severe variant characterized by: - Sudden onset of widespread erythema with sterile pustules - Systemic symptoms: fever, malaise, arthralgia - Electrolyte disturbances (hypokalemia, hypocalcemia) - Risk of sepsis and death if untreated - Triggers: infection, pregnancy, drugs (lithium, NSAIDs, abrupt corticosteroid withdrawal) ### Why Cyclosporine in This Scenario? 1. **Rapid Onset:** Response within 2–4 weeks (faster than methotrexate's 4–8 weeks) 2. **Potent Anti-inflammatory:** Blocks IL-2 and T-cell activation, rapidly controlling the acute flare 3. **Systemic Effect:** Addresses systemic toxicity and fever 4. **No Teratogenicity Concern:** Patient is 42 years old (post-reproductive age) 5. **Proven Efficacy:** 70–80% response rate in acute pustular psoriasis ### Dosing in Acute Pustular Psoriasis - **Initial dose:** 3–5 mg/kg/day (divided into two doses) - **Monitoring:** Serum creatinine, blood pressure, trough levels (100–200 ng/mL) - **Duration:** 8–12 weeks, then taper or switch to maintenance therapy ### Monitoring Requirements | Parameter | Baseline | Frequency | |-----------|----------|----------| | Serum creatinine | Yes | Every 2 weeks | | Blood pressure | Yes | Every visit | | Cyclosporine trough level | Yes | Every 2–4 weeks | | Electrolytes (K⁺, Ca²⁺, Mg²⁺) | Yes | Weekly (acute phase) | | LFTs | Yes | Every 4 weeks | **Clinical Pearl:** Cyclosporine can cause acute renal dysfunction (reversible if caught early), hypertension, and hyperkalemia. Close monitoring is essential. In this acute setting with systemic toxicity, the benefits outweigh the risks. **Warning:** Do NOT use methotrexate in acute pustular psoriasis — it is slow-acting and unsuitable for life-threatening flares. Do NOT use acitretin as monotherapy in Zumbusch type; it is slower than cyclosporine and better suited for chronic pustular forms. ### Treatment Algorithm for Pustular Psoriasis ```mermaid flowchart TD A[Pustular Psoriasis Diagnosed]:::outcome --> B{Acute systemic symptoms<br/>& toxicity?}:::decision B -->|Yes| C[Cyclosporine 3-5 mg/kg/day]:::action B -->|No| D{Localized or<br/>chronic form?}:::decision D -->|Localized| E[Topical corticosteroids<br/>+ Acitretin]:::action D -->|Chronic generalized| F[Acitretin or MTX]:::action C --> G[Rapid response<br/>2-4 weeks]:::outcome G --> H{Remission achieved?}:::decision H -->|Yes| I[Switch to MTX or Acitretin<br/>for maintenance]:::action H -->|No| J[Consider biologics<br/>or combination therapy]:::action ``` **Mnemonic:** **CYCLO for CRISIS** — Cyclosporine for acute pustular psoriasis in Crisis (systemic toxicity). Methotrexate for Maintenance; Acitretin for chronic pustular forms.